Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Soliris 300 mg concentrate for solution for infusion

Active Ingredient:
eculizumab
Company:  
Alexion Pharma UK Ltd See contact details
ATC code: 
L04AA25
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Soliris Patient Safety Card

Important Safety Information for Patients Receiving Soliris® Show this card to any doctor involved in your care.
{pdf_link}

Soliris Patient/Parent Information

This guide is for adult patients and parents/legal guardians of a child who has been prescribed eculizumab. The guide provides you with important safety information that you must be aware of.
{pdf_link}

Soliris Physician's Guide

{healthcare_pro_orange} For Healthcare Professionals
The aim of this brochure is to educate and/or remind healthcare professionals about the selected prevention measures, detection, careful monitoring and/or proper management of selected safety concerns associated with eculizumab.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Alexion Pharma UK Ltd
Company image
Address
2 Pancras Square, London, N1C 4AG, UK
Telephone
+44 (0) 208 744 6600
Fax
+44 (0) 20 8744 6630
Medical Information Direct Line
0800 028 4394
Customer Care direct line
0800 1300 212
Medical Information e-mail
[email protected]